RGC shares jump on trading volume 14 times above average amid signs of a short squeeze.
Regencell Bioscience (RGC) surged approximately 35% in early trading on unusually high volume, suggesting a short squeeze. By 2:25 p.m. ET, 2.18M shares had traded, compared to an average daily volume of 151K.
Despite the rally, RGC remains down 61% year-to-date and 44% over the past 12 months. The stock’s recent performance contrasts sharply with today’s spike, driven by elevated trading activity.
No immediate market reaction details were provided beyond the price and volume surge.